These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

387 related items for PubMed ID: 2544876

  • 1. Accessibility of receptor-bound urokinase to type-1 plasminogen activator inhibitor.
    Cubellis MV, Andreasen P, Ragno P, Mayer M, Danø K, Blasi F.
    Proc Natl Acad Sci U S A; 1989 Jul; 86(13):4828-32. PubMed ID: 2544876
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of receptor-bound urokinase by plasminogen-activator inhibitors.
    Ellis V, Wun TC, Behrendt N, Rønne E, Danø K.
    J Biol Chem; 1990 Jun 15; 265(17):9904-8. PubMed ID: 2161846
    [Abstract] [Full Text] [Related]

  • 3. A hybrid protein of urokinase growth-factor domain and plasminogen-activator inhibitor type 2 inhibits urokinase activity and binds to the urokinase receptor.
    Ballance DJ, Marshall JM, Cottingham IR, Steven J, Berry SJ, Cederholm-Williams SA, Goodey AR, Courtney M.
    Eur J Biochem; 1992 Jul 01; 207(1):177-83. PubMed ID: 1321039
    [Abstract] [Full Text] [Related]

  • 4. Receptor-mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI-1.
    Cubellis MV, Wun TC, Blasi F.
    EMBO J; 1990 Apr 01; 9(4):1079-85. PubMed ID: 2157592
    [Abstract] [Full Text] [Related]

  • 5. Internalization of the urokinase-plasminogen activator inhibitor type-1 complex is mediated by the urokinase receptor.
    Olson D, Pöllänen J, Høyer-Hansen G, Rønne E, Sakaguchi K, Wun TC, Appella E, Danø K, Blasi F.
    J Biol Chem; 1992 May 05; 267(13):9129-33. PubMed ID: 1315748
    [Abstract] [Full Text] [Related]

  • 6. Purified alpha 2-macroglobulin receptor/LDL receptor-related protein binds urokinase.plasminogen activator inhibitor type-1 complex. Evidence that the alpha 2-macroglobulin receptor mediates cellular degradation of urokinase receptor-bound complexes.
    Nykjaer A, Petersen CM, Møller B, Jensen PH, Moestrup SK, Holtet TL, Etzerodt M, Thøgersen HC, Munch M, Andreasen PA.
    J Biol Chem; 1992 Jul 25; 267(21):14543-6. PubMed ID: 1378833
    [Abstract] [Full Text] [Related]

  • 7. Regions involved in binding of urokinase-type-1 inhibitor complex and pro-urokinase to the endocytic alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Evidence that the urokinase receptor protects pro-urokinase against binding to the endocytic receptor.
    Nykjaer A, Kjøller L, Cohen RL, Lawrence DA, Garni-Wagner BA, Todd RF, van Zonneveld AJ, Gliemann J, Andreasen PA.
    J Biol Chem; 1994 Oct 14; 269(41):25668-76. PubMed ID: 7929271
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Characterization of the cellular binding site for the urokinase-type plasminogen activator.
    Estreicher A, Wohlwend A, Belin D, Schleuning WD, Vassalli JD.
    J Biol Chem; 1989 Jan 15; 264(2):1180-9. PubMed ID: 2536017
    [Abstract] [Full Text] [Related]

  • 11. Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase.
    Vines DJ, Lee SW, Dichek DA, Ellis V.
    J Pept Sci; 2000 Sep 15; 6(9):432-9. PubMed ID: 11016879
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of cancer cell urokinase plasminogen activator by its specific inhibitor PAI-2 and subsequent effects on extracellular matrix degradation.
    Baker MS, Bleakley P, Woodrow GC, Doe WF.
    Cancer Res; 1990 Aug 01; 50(15):4676-84. PubMed ID: 2114945
    [Abstract] [Full Text] [Related]

  • 13. Urokinase-type plasminogen activator/type-2 plasminogen-activator inhibitor complexes are not internalized upon binding to the urokinase-type-plasminogen-activator receptor in THP-1 cells. Interaction of urokinase-type plasminogen activator/type-2 plasminogen-activator inhibitor complexes with the cell surface.
    Ragno P, Montuori N, Rossi G.
    Eur J Biochem; 1995 Oct 15; 233(2):514-9. PubMed ID: 7588796
    [Abstract] [Full Text] [Related]

  • 14. The pro-urokinase plasminogen-activation system in the presence of serpin-type inhibitors and the urokinase receptor: rescue of activity through reciprocal pro-enzyme activation.
    Behrendt N, List K, Andreasen PA, Danø K.
    Biochem J; 2003 Apr 15; 371(Pt 2):277-87. PubMed ID: 12534347
    [Abstract] [Full Text] [Related]

  • 15. Prourokinase activation on the surface of human rhabdomyosarcoma cells: localization and inactivation of newly formed urokinase-type plasminogen activator by recombinant class 2 plasminogen activator inhibitor.
    Pöllänen J, Vaheri A, Tapiovaara H, Riley E, Bertram K, Woodrow G, Stephens RW.
    Proc Natl Acad Sci U S A; 1990 Mar 15; 87(6):2230-4. PubMed ID: 2138329
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Binding of single-chain prourokinase to the urokinase receptor of human U937 cells.
    Cubellis MV, Nolli ML, Cassani G, Blasi F.
    J Biol Chem; 1986 Dec 05; 261(34):15819-22. PubMed ID: 3023326
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Structural requirements for the growth factor activity of the amino-terminal domain of urokinase.
    Rabbani SA, Mazar AP, Bernier SM, Haq M, Bolivar I, Henkin J, Goltzman D.
    J Biol Chem; 1992 Jul 15; 267(20):14151-6. PubMed ID: 1321137
    [Abstract] [Full Text] [Related]

  • 20. Kinetics of reciprocal pro-urokinase/plasminogen activation--stimulation by a template formed by the urokinase receptor bound to poly(D-lysine).
    Petersen LC.
    Eur J Biochem; 1997 Apr 15; 245(2):316-23. PubMed ID: 9151959
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.